Best Artificial Pancreas Podcasts (2024)

1
Eyal Dassau on Innovations in Diabetes Management and Connected Care 17:20

7d ago17:20

17:20

A conversation on the future of diabetes care with Eyal Dassau, PhD, Vice President of Innovation and Connected Care at Lilly,By David Klonoff and David Kerr

1
Greta Ehlers on Diabetes Center Berne and Innovation in Diabetes Technology 12:45

30d ago12:45

12:45

A conversation on innovation in diabetes technology with Greta Ehlers, MS, Business Scout at Diabetes Center Berne.By David Klonoff and David Kerr

1
Diabetes and CKD: Strategies for Diagnosis and Treatment

1M ago

—

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Ian de Boer, MD Since up to 40 percent of patients with diabetes develop diabetic kidney disease, it’s essential to know how to proactively diagnose and treat them using the latest therapeutic advances and strategies. Tune in to hear Dr. Mary Katherine Cheeley discuss diabetes management …

1
Michael Brown on the Intersection of Culture, Technology, and Diabetes Care in South Africa 18:59

1M ago18:59

18:59

A conversation on diabetes care and education in South Africa with Michael Brown, RN, Head of the CDE Academy and co-host of the "not ARTIFICIALLY Sweetened" diabetes podcast.By David Klonoff and David Kerr

1
Uncovering the Prevalence of Type 1 Diabetes in Older Adults

2M ago

—

Guest: Elena Toschi, MD Approximately over the last decade, lifespans in the general population have increased, along with a rise in the prevalence of type 1 diabetes in older adult patients. Since each patient has a unique disease, the clinician should personalize and devise the best approach to diabetes management and glycemic targets, as well as…

1
Concentrating on the MOMPOD Trial for Metformin Plus Insulin

3M ago

—

Host: John Buse, MD, PhD Guest: Kim Boggess, MD The most common forms of diabetes encountered in pregnant patients include gestational diabetes and preexisting type 2 diabetes. So how does adding metformin to insulin treatment help these patients? Join Dr. John Buse as he talks about the MOMPOD Trial with lead author, Dr. Kim Boggess, Professor of …

1
Utilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients

3M ago

—

Guest: R. Paul Wadwa, M.D. Since young kids have a different activity level and diet than older kids or adult patients, controlling type 1 diabetes in younger patients can be more challenging, and there tends to be more variability in their blood sugars. However, a recent study identified that hybrid closed-loop technology could help give children …

1
Osagie Ebekozien on Technology, Equity, and Collaboration in Type 1 Diabetes Care 15:28

3M ago15:28

15:28

An interview on technology, equity, and collaboration in type 1 diabetes care with Osagie Ebekozien, MD, MPH, CPHQ, Executive Vice President and Chief Medical Officer of T1D Exchange.By David Klonoff and David Kerr

1
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients

3M ago

—

Host: Carol Wysham, MD Guest: A. Michael Lincoff, MD Given the growing evidence that obesity is associated with increased cardiovascular risk, a recent study assessed the impact of semaglutide on cardiovascular outcomes in patients who are overweight or obese but do not have diabetes. Not only did semaglutide reduce the risk of cardiovascular death…

1
Overcoming Obesity: Insights from the SURMOUNT-4 Trial

3M ago

—

Host: John Buse, MD, PhD Guest: Louis J. Aronne, MD, FTOS In the SURMOUNT-4 trial, 100 patients with obesity were on tirezpatide for 9 months, and the average weight loss was 20.9 percent. The patients were then randomized to receive either placebo with behavioral intervention or tirzepatide for another year, and the patients in the former group re…

1
Bob Gabbay on Diabetes Management and Emerging Technologies 15:27

3M ago15:27

15:27

An interview on diabetes management and emerging technologies with Robert A. Gabbay, MD, PhD, Chief Scientific and Medical Officer of the American Diabetes Association.By David Klonoff and David Kerr

1
Anne Peters on Bridging Healthcare Gaps with Diabetes Technology and Education 15:49

4M ago15:49

15:49

Interview on diabetes technology and care in underserved patient populations with Anne Peters, MD, Professor of Medicine at the Keck School of Medicine of USC and Director of the USC Clinical Diabetes ProgramsBy David Klonoff and David Kerr

1
Mike Jaasma on Spinal Cord Stimulation for Diabetic Neuropathy 15:43

5M ago15:43

15:43

An interview on spinal cord stimulation for diabetic neuropathy with Michael Jaasma, PhD, Principal Clinical Research Scientist at Nevro.By David Klonoff and David Kerr

1
Strategies for Addressing Diabetes Stigma and Discrimination

5M ago

—

Host: John Buse, MD, PhD Guest: Mary de Groot, PhD The prevalence of diabetes-related stigma is alarmingly high. In fact, four in five adults have reported experiencing some form of diabetes stigma at some point in their lives. To learn how we as healthcare providers can help reduce this burden for our patients with diabetes, Dr. John Buse speaks w…

1
Robert Lustig on Rethinking Sugar, Diet, and Health Through Insulin Dynamics 20:30

5M ago20:30

20:30

An interview on rethinking sugar, diet, and health through the lens of insulin dynamics with Robert Lustig, MD, Professor of Pediatric Endocrinology at UCSF.By David Klonoff and David Kerr

1
How the Artificial Pancreas Can Help Diabetic Patients

6M ago

—

Host: Stuart Weinzimer, MD The artificial pancreas represents the integration of two separate devices: a continuous glucose monitor and an insulin pump. Learn more about this technology and how it can help improve diabetic patients’ quality of life with Dr. Stuart Weinzimer, Interim Section Chief of Pediatric Endocrinology and Diabetes at Yale Scho…

1
Using CGMs and Insulin Pumps to Treat Pediatric Patients with T1D

6M ago

—

Host: Stuart Weinzimer, MD From continuous glocuose monitors to insulin pumps, there have been immense technological advancements for patients with type 1 diabetes. Learn more about how these two tools can be used to treat pediatric patients with type 1 diabetes with Dr. Stuart Weinzimer, Interim Section Chief of Pediatric Endocrinology and Diabete…

1
Guido Freckmann on CGM Standards and Accuracy 15:19

7M ago15:19

15:19

An interview on CGM accuracy and standardization with Guido Freckmann, MD, Medical Director of the Institute for Diabetes Technology Research at Ulm University in Germany.By David Klonoff and David Kerr

1
Challenging the Misconception That T1D Is a Childhood-Onset Disease

7M ago

—

Host: John Buse, MD, PhD Guest: Michael Fang, PhD According to a recent study published in the Annals of Internal Medicine, the median age of patients with type 1 diabetes is 24. However, type 1 diabetes that develops in adulthood is often mistakenly identified as type 2 diabetes, resulting in improper treatment. Joining Dr. John Buse to review thi…

1
Decoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1D

7M ago

—

Host: John Buse, MD, PhD Guest: Maria Jose Redondo, MD, PhD, MPH A recent paper focused on a variety of topics associated with type 1 diabetes, including its heterogenenity, endotypes, slowly progressive insulin-dependent diabetes, and the term type 1.5 diabetes. Dive into these topics with Dr. John Buse and Dr. Maria Redondo, Professor of Pediatri…

1
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D

7M ago

—

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: David Selzer, MD New research suggests that a GLP-1 receptor agonist medication, semaglutide, which has been approved for type 2 diabetes and obesity, could also be used to treat type 1 diabetes in patients. So what are the risks for patients who have type 1 diabetes and who are obese? Jo…

1
Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients

7M ago

—

Host: John Buse, MD, PhD Guest: Helen Murphy, PhD There are many challenges associated with managing type 1 diabetes (T1D) in pregnant patients, which is why a recent study examined the use of an automated insulin delivery system in this patient population. Using this method, insulin doses were adjusted every 8 to 10 minutes according to a patient’…

1
How Overnight Glucose Levels Impact Daily Activities in T1D Patients

8M ago

—

Host: John Buse, MD, PhD Guest: Beth Pyatak, PhD, OTR/L According to a recent study, fluncuations in glucose levels while sleeping can directly impact type 1 diabetes patients’ ability to complete daily activities. In fact, it was found that higher variability overnight led to lower sustained attention and lower engagement in demanding activities t…

1
Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts

8M ago

—

Host: John Buse, MD, PhD Guest: Simon Heller, MD Amid the crisis around the cost of diabetes care worldwide, biosimilar insulins could help save millions of dollars and allow more patients to be treated safely and effectively. But how exactly are these products approved, and how do they compare to the original product? Find out with Dr. John Buse a…

1
Educating Providers and Patients About Insulin Biosimilars

8M ago

—

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Elizabeth Cook, PharmD, AE-C, BCACP, CDCES With a shortage of insulin products in the United States, our diabetic patients are left without lifesaving medications, making this a prominent barrier in clinical practice. However, insulin biosimilars may offer more accessibility and affordabi…

1
How Ultra-Processed Foods Increase the Risk of Type 2 Diabetes

8M ago

—

Host: John Buse, MD, PhD Guest: Jean-Philippe Drouin-Chartier, DtP, PhD What’s the relationship between ultra-processed food consumption and the risk of developing type 2 diabetes? Find out with Dr. John Buse as he speaks with Dr. Jean-Philippe Drouin-Chartier about his research that sought to answer this exact question. Dr. Drouin-Chartier is an A…

1
Jorge Cuadros on AI Detection of Diabetic Retinopathy and Beyond 13:24

9M ago13:24

13:24

An interview on AI detection of diabetic retinopathy and other diseases with Jorge Cuadros, Director of Clinical Informatics Research in the Department of Optometry and Vision Science at UC Berkeley, and the CEO of IPACS.By David Klonoff and David Kerr

1
Grazia Aleppo on Integrating CGM Data into the Electronic Health Record 14:22

9M ago14:22

14:22

An interview on integrating CGM data into the EHR with Grazia Aleppo, Professor of Medicine at Northwestern University.By David Klonoff and David Kerr

1
Recapping a Narrative Review on the Management of Chronic Kidney Disease in T2D

9M ago

—

Host: John Buse, MD, PhD Guest: David Cherney, MD, PhD There have been several major advances regarding the management of chronic kidney disease in patients with type 2 diabetes over the last 5 years, leading Dr. David Cherney and a team of authors to publish a narrative review on how to best manage these patients using the latest treatment options…

1
William Polonsky on the Psychology of Diabetes Technology 16:51

9M ago16:51

16:51

An interview on the psychology of diabetes technology with William Polonsky, Associate Clinical Professor in Psychiatry at UC San Diego and president of the Behavioral Diabetes Institute.By David Klonoff and David Kerr

1
The Impact of RADIANT: A Deep Dive into the Study

9M ago

—

Host: John Buse, MD, PhD Guest: Louis Philipson, MD, PhD Over the last 15 years, the monogenic diabetes registry now has over 4,000 patients involved, and from that, the RADIANT study was started to identify new kinds of rare and atypical diabetes. So how can genetics testing and the RADIANT study provide atypical diabetes patients with better diag…

1
Guiding Principles of Treating Gestational Diabetes

9M ago

—

Host: John Buse, MD, PhD Guest: David Simmons, MD Gestational hypertension is more common in preeclampsia, and there’s more chance of the baby ending up in the neonatal intensive care unit. So what can we learn from the randomized trials of women patients with gestational diabetes? Learn more with Dr. John Buse as he speaks with Dr. David Simmons, …

1
Doug Kanter on Designing the CGM Experience 17:32

10M ago17:32

17:32

An interview on Designing the CGM Experience with Doug Kanter, Director of User Experience Design at Dexcom.By David Klonoff and David Kerr

1
David Armstrong on the Diabetic Foot 18:24

11M ago18:24

18:24

Interview on the diabetic foot with David G. Armstrong, Professor of Surgery at the University of Southern California.By David Klonoff and David Kerr

1
How Diet Can Affect the Gut Microbiome

11M ago

—

Host: John Buse, MD, PhD Guest: Karen D. Corbin, PhD, RD One of the biggest missing links in current literature about obesity and the gut microbiome was causality. In an effort to address that gap, a recent clinical trial was conducted, and now, the results are in. So what were the key findings, and how can we translate those findings into clinical…

1
Disease Spotlight: Reflecting on Liver Health in Diabetes Care

11M ago

—

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Suijit Janardhan, MD, PhD Diabetic patients have a significant risk for developing more advanced liver disease, and the disease that they’re particularly at risk for is steatotic liver disease. Dive into this episode to learn more with Dr. Charles Turck and Dr. Sujit Janardhan, Assistant Professor in …

1
Jane Seley on Diabetes Technology in the Hospital 13:32

11M ago13:32

13:32

Interview on diabetes technology in the hospital with Jane Seley, assistant professor of medicine, nurse practitioner, and diabetes care and education specialist at Weill Cornell Medicine.By David Klonoff and David Kerr

1
Key Considerations for CGM Use in Older Adults with T1D

12M ago

—

Host: John Buse, MD, PhD Guest: Anna Kahkoska, MD, PhD Continuous glucose monitoring (CGM) can help improve glycemic management in patients with type 1 diabetes (T1D), but integrating this technology can be a complex learning process for older adults. So what do we need to consider when it comes to CGM use in older adults? Find out with Dr. John Bu…

1
Jeffrey Joseph on Devices for Monitoring & Treating Diabetes and Safely Delivering Insulin 12:33

1y ago12:33

12:33

Interview with inventor and anesthesiologist Jeffrey Joseph, DO about devices for monitoring & treating diabetes and safely delivering insulin.By David Klonoff, David Kerr, and Jeffrey Joseph

1
Lutz Heinemann on the Sustainability of Diabetes Devices and the Green Diabetes Initiative 13:51

1y ago13:51

13:51

Interview with engineer and physiologist Lutz Heinemann about sustainability of diabetes devices and the Green Diabetes Initiative.By David Klonoff, David Kerr, and Lutz Heinemann

1
Vitamin D Can Reduce the Risk of T2D in Prediabetic Patients

1y ago

—

Host: John Buse, MD, PhD Guest: Anastassios Pittas, MD, MS Vitamin D has numerous benefits, and according to a recent study, it can even help reduce the risk of type 2 diabetes in patients with prediabtes. Learn more about the key findings from this research with Dr. John Buse and Dr. Anastassios Pittas, Professor of Medicine and Chief of Endocrino…

1
How Hypoglycemia Can Lead to Unsafe Driving Practices in T1D Patients

1y ago

—

Host: John Buse, MD, PhD Guest: Viral Shah, MD Severe hypoglycemia can lead to dangerous challenges, one of them being an increase in vehicular accidents. Dive into the results from a study that investigated the correlation between the prevalence of hypoglycemia while driving in adults with type 1 diabetes (T1D) and how many of those cases might ha…

1
Investigating the Impact of Bempedoic Acid on Cardiovascular Outcomes in Statin-Intolerant Patients

1y ago

—

Host: John Buse, MD, PhD Guest: Steven Nissen, MD Among statin-intolerant patients, treatment with bempedoic acid is associated with a lower risk of major adverse cardiovascular events according to a recent study. Dive into the study’s key findings with Dr. John Buse and Dr. Steven Nissen, who published the placebo-controlled study of bempedoic aci…

1
Addressing Gaps to Tackle Obesity in Patients with Type 1 Diabetes

1y ago

—

Host: John Buse, MD, PhD Guest: Elizabeth Selvin, PhD, MPH As obesity rates continue to rise in adults with type 1 diabetes, what can we do to combat this growing obstacle? Dr. John Buse speaks with an expert in the field, Dr. Elizabeth Selvin, about obesity in patients with type 1 diabetes and shares management strategies.…

1
Maximizing Weight Loss & Minimizing Side Effects With GLP-1

1+ y ago

—

Host: John Buse, MD, PhD Guest: Ania Jastreboff, MD, PhD Counseling patients with obesity who are on GLP-1 receptor agonists can be challenging. How can we leverage the biology of GLP-1 receptor antagonists to improve weight loss while avoiding side effects? Dr. John Buse speaks with a leading expert in the field, Dr. Ania Jastreboff, about the rol…

1
Closing Gaps in Care for Patients with T2D & CV Disease

1+ y ago

—

Host: John Buse, MD, PhD Guest: Jennifer B. Green, MD The COORDINATE Study evaluated patients with cardiovascular disease and type 2 diabetes who encounter barriers in receiving newer diabetes medications. To better understand these gaps in care, Dr. John Buse speaks with one of the researchers, Dr. Jennifer Green from Duke University in Durham, No…

1
Adapting Our Exercise Talk: Key Tips on Counseling Patients on Exercise

1+ y ago

—

Host: John Buse, MD, PhD Guest: Abbie E. Smith-Ryan, PhD, CSCS*D, FNSCA There are immeasurable benefits to exercise, but the hard part for patients may be getting started. How can we help our patients make exercise a part of their lives? Dr. John Buse speaks with Dr. Abbie Smith-Ryan, a Professor of Exercise Physiology at the University of North Ca…

1
Insights from Obesity Canada: A Deep Dive into Guideline Updates

1+ y ago

—

Host: John Buse, MD, PhD Guest: Sue Pedersen, MD, FRCPC New guidelines published by Obesity Canada take a deep dive into pharmacotherapy and feature the latest recommendations on comorbidities and decision tools. To better understand the impact of these guidelines, Dr. John Buse speaks with one of the guidelines authors, Dr. Sue Pedersen, a special…

1
Key Therapeutic Insights on Semaglutide in Adolescent Obesity

1+ y ago

—

Host: John Buse, MD, PhD Guest: Silva Arslanian, MD New research on once-daily semaglutide for adolescent patients with obesity may alter clinicians’ approach to care. What do we need to know? Dr. John Buse speaks with one of the study’s investigators, Dr. Silva Arslanian, from the University of Pittsburgh to dive into this clinical data and explor…

1
Explore Impacts Of Glucose-Lowering Medications in Addition to Metformin

1+ y ago

—

Host: John Buse, MD, PhD Guest: Jennifer B. Green, MD What does the latest research on glycemia reduction show us about the impact of glucose-lowering medication in combination with metformin on microvascular and cardiovascular outcomes in patients with type 2 diabetes? Dr. John Buse speaks with one of the study’s investigators, Dr. Jennifer Green,…

Podcasts Worth a Listen

Artificial Pancreas Podcasts

Podcasts Worth a Listen

Quick Reference Guide